BP
Bayer AG Pharmaceuticals Division (Berlin). 2024 revenue ~€18B. Eylea (aflibercept), Xarelto, Aspirin. Radiology: Ultravist, Gadovist. Cell & Gene Therapy. Women's health: Mirena, Kyleena.
Impressive R&D pipeline. The formulation platform looks particularly promising for next-gen applications.
8:28:25 PM · Jul 9, 2026
Sign in to reply and join the conversation.